Key result
DHEA treatment in diabetic rats improved oxidative balance, minimized structural changes, and completely restored the contractility of isolated papillary muscle.
Why the study?
Does dehydroepiandrosterone (DHEA) prevent cardiac fibrosis and impaired contractile function in rats with streptozotocin-induced diabetes?
Does dehydroepiandrosterone (DHEA) prevent cardiac fibrosis and impaired contractile function in rats with streptozotocin-induced diabetes?
In a rat model of diabetic cardiomyopathy, DHEA treatment minimized structural changes and restored cardiac muscle function by reducing oxidative stress and fibrosis.
Answers are grounded in this paper and cite their sources.
DHEA merits testing in human diabetic cardiomyopathy trials; leaves open translation beyond rodent models.
Diabetic cardiomyopathy is characterized by myocyte loss and myocardial fibrosis, leading to decreased elasticity and impaired contractile function. The study examines the downstream signaling whereby oxidative stress, induced by hyperglycemia, leads to myocardial fibrosis and impaired contractile function in the left ventricle of diabetic rats. It also examines the effects of dehydroepiandrosterone (DHEA), which prevents the oxidative damage induced by hyperglycemia in experimental models. DHEA was administered for 6 wk in the diet [0.02%, wt/wt)] to rats with streptozotocin-induced diabetes. Oxidative balance, advanced glycated end products (AGEs) and AGE receptors, transcription factors nuclear factor-kappaB and activator protein-1, and profibrogenic growth factors (connective tissue growth factor and TGFbeta1) were determined in the left ventricle of treated and untreated streptozotocin-diabetic rats. Structural and ultrastructural changes, and the contractile force developed by electrically driven papillary muscles, under basal conditions and after stimulation with isoproterenol, were also evaluated. Oxidative stress induced by hyperglycemia increased AGEs and AGE receptors and triggered a cascade of signaling, eventually leading to interstitial fibrosis. DHEA treatment, by improving oxidative balance, counteracted the enhanced AGE receptor activation and increase of profibrogenic factors and restored tissue levels of collagen I, collagen IV, and fibronectin to those of control animals. Moreover, DHEA completely restored the contractility of isolated papillary muscle. Oxidative stress led to cardiac fibrosis, the most important pathogenetic factor of the heart's impaired functional integrity in diabetes. Structural and ultrastructural changes and impairment of muscle function induced by experimental diabetes were minimized by DHEA treatment.
No takes yet. Share an insight, caveat, or question.
Aragno et al. (2007) studied Diabetic cardiomyopathy. Dehydroepiandrosterone (DHEA) vs. Untreated streptozotocin-diabetic rats was evaluated on Oxidative balance, AGEs, AGE receptors, transcription factors, profibrogenic growth factors, structural changes, and contractile force. DHEA treatment in diabetic rats improved oxidative balance, minimized structural changes, and completely restored the contractility of isolated papillary muscle.
Synapse has enriched 10 related papers. Consider them for comparative context: